Advanced Imaging Research Center, UT Southwestern Medical Center, 5323 Harry Hines Blvd, NE 4.210, Dallas, TX, 775390-8568, USA.
Department of Radiology, UT Southwestern Medical Center, Dallas, TX, 7575390-8896, USA.
Mol Imaging Biol. 2023 Oct;25(5):935-943. doi: 10.1007/s11307-023-01821-w. Epub 2023 Apr 25.
Recently, we reported that exposure of prostate cells in vitro or the in vivo prostate to high glucose results in release of Zn ions, a process now referred to as glucose-stimulated zinc secretion (GSZS). To our knowledge, the metabolic event(s) that trigger GSZS remain largely unknown. Here, we explore several signaling pathways both in vitro using a prostate epithelial cell line and in vivo from the rat prostate.
PNT1A cells grown to confluence were washed and tagged with ZIMIR to monitor zinc secretion by optical methods. The expression levels of GLUT1, GLUT4, and Akt in cells cultured in either zinc-rich or zinc-poor media and after exposure to high versus low glucose were determined. Zinc secretion from the rat prostate in vivo as detected by MRI was compared in control animals after injection of glucose, deoxyglucose, or pyruvate to initiate zinc secretion and in animals pre-treated with WZB-117 (a GLUT1 inhibitor) or S961 (a peripheral insulin receptor inhibitor).
PNT1A cells exposed to high levels of glucose secrete zinc whereas cells exposed to an equivalent amount of deoxyglucose or pyruvate do not. Expression of Akt was dramatically altered by zinc supplementation of the culture media but not after exposure to glucose while GLUT1 and GLUT4 levels were less affected. Rats pre-treated with WZB-117 prior to imaging showed a reduction in GSZS from the prostate compared to controls whereas rats pre-treated with S961 showed no difference. Interestingly, in comparison to PNT1A cells, pyruvate and deoxyglucose also stimulate zinc secretion in vivo likely through indirect mechanisms.
GSZS requires metabolism of glucose both in vitro (PNT1A cells) and in vivo (rat prostate). Pyruvate also stimulates zinc secretion in vivo but likely via an indirect pathway involving rapid production of glucose via gluconeogenesis. These combined results support the conclusion that glycolytic flux is required to trigger GSZS in vivo.
最近,我们报道了体外培养的前列腺细胞或体内前列腺暴露于高葡萄糖环境中会导致锌离子释放,这一过程现被称为葡萄糖刺激的锌分泌(GSZS)。据我们所知,触发 GSZS 的代谢事件(多个)在很大程度上仍不清楚。在这里,我们使用前列腺上皮细胞系在体外和从大鼠前列腺在体内探索了几种信号通路。
将生长至汇合的 PNT1A 细胞洗涤并用 ZIMIR 标记以通过光学方法监测锌分泌。在锌丰富或锌缺乏培养基中培养的细胞以及暴露于高糖和低糖后的 GLUT1、GLUT4 和 Akt 的表达水平进行了测定。通过 MRI 检测到的大鼠前列腺在体内的锌分泌在注射葡萄糖、脱氧葡萄糖或丙酮酸以启动锌分泌后的对照动物以及在预先用 WZB-117(GLUT1 抑制剂)或 S961(外周胰岛素受体抑制剂)预处理的动物中进行了比较。
暴露于高浓度葡萄糖的 PNT1A 细胞会分泌锌,而暴露于等量的脱氧葡萄糖或丙酮酸的细胞则不会。培养基中锌的补充会显著改变 Akt 的表达,但暴露于葡萄糖后不会,而 GLUT1 和 GLUT4 的水平受影响较小。在成像前用 WZB-117 预处理的大鼠与对照组相比,前列腺的 GSZS 减少,而用 S961 预处理的大鼠则没有差异。有趣的是,与 PNT1A 细胞相比,丙酮酸和脱氧葡萄糖也在体内刺激锌分泌,可能通过间接机制。
GSZS 既需要体外(PNT1A 细胞)又需要体内(大鼠前列腺)的葡萄糖代谢。丙酮酸也刺激体内的锌分泌,但可能通过涉及糖异生的快速产生葡萄糖的间接途径。这些综合结果支持了这样的结论,即糖酵解通量是触发体内 GSZS 所必需的。